Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Meseure, Didier ^a   Alsibai, Kinan Drak ^a   Nicolas, Andre ^a   Bieche, Ivan ^b   Morillon, Antonin ^a  

^a INSTITUT CURIE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ANTISENSE UNTRANSLATED RNA IN THE INK4 LOCUS; APTAMER; BIOLOGICAL MARKER; COMPLEMENTARY RNA; CYCLIN D1; GROWTH ARREST SPECIFIC 5; HIGHLY UPREGULATED IN LIVER CANCER; HOX ANTISENSE INTERGENIC RNA; LONG UNTRANSLATED RNA; MATERNALLY EXPRESSED GENE 3; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; MICRORNA; MICRORNA 145; PROSTATE CANCER GENE EXPRESSION MARKER 1; PROTEIN P21; RIBOZYME; RNA H19; SMALL INTERFERING RNA; SPACER DNA; STEROID RECEPTOR; STEROID RECEPTOR RNA ACTIVATOR; TELOMERASE; TELOMERIC REPEAT CONTAINING RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; RNA; TUMOR MARKER;

BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER GENETICS; CANCER PROGNOSIS; CARCINOGENESIS; DIGESTIVE SYSTEM CANCER; ENHANCER REGION; EPIGENETICS; ESOPHAGUS CANCER; GENE FUNCTION; GENE TARGETING; GENETIC CONSERVATION; GENOME; GLIOMA; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; LIVER CANCER; LOWER DIGESTIVE TRACT CANCER; LUNG CANCER; MEDICAL PRACTICE; MELANOMA; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; NEOPLASM; OVARY CANCER; PHENOTYPIC PLASTICITY; PROMOTER REGION; PROSTATE CANCER; REVIEW; RNA ANALYSIS; RNA STRUCTURE; RNA TRANSCRIPTION; STOMACH CANCER; TUMOR SUPPRESSOR GENE; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; METABOLISM; NEOPLASMS; PATHOLOGY; PROGNOSIS;

ANIMALS; BIOMARKERS, TUMOR; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; PROGNOSIS; RNA, LONG NONCODING; RNA, NEOPLASM;

EID: 84942801829     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/320214     Document Type: Review

References (100)

1. S.Djebali, C. A.Davis, A.Merkel et al., "Landscape of transcription in human cells," Nature, vol. 489, no. 7414, pp. 101-108, 2012.
2. M. K. Iyer, Y. S. Niknafs, R. Malik et al., "The landscape of long noncoding RNAs in the human transcriptome," Nature Genetics, vol. 47, no. 3, pp. 199-208, 2015.
3. R. J. Taft, K. C. Pang, T. R.Mercer, M. Dinger, and J. S. Mattick, "Non-coding RNAs: regulators of disease," Journal of Pathology, vol. 220, no. 2, pp. 126-139, 2010.
4. E. A. Gibb, K. S. S. Enfield, G. L. Stewart et al., "Long noncoding RNAs are expressed in oral mucosa and altered in oral premalignant lesions," Oral Oncology, vol. 47, no. 11, pp. 1055-1061, 2011.
5. J.M. Perkel, "Visiting 'Noncodarnia'," BioTechniques, vol. 54, no. 6, pp. 301-304, 2013.
6. K. C. Pang,M. C. Frith, and J. S. Mattick, "Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function," Trends in Genetics, vol. 22, no. 1, pp. 1-5, 2006.
7. O. Wapinski and H. Y. Chang, "Long noncoding RNAs and human disease," Trends in Cell Biology, vol. 21, no. 6, pp. 354-361, 2011.
8. S. Ye, L. Yang, X. Zhao, W. Song, W. Wang, and S. Zheng, "Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer," Cell Biochemistry and Biophysics, vol. 70, no. 3, pp. 1849-1858, 2014.
9. Q. Jiang, J. Wang, Y. Wang, R. Ma, X. Wu, and Y. Li, "TF2LncRNA: identifying common transcription factors for a list of lncRNA genes from ChIP-seq data," BioMed Research International, vol. 2014,Article ID 317642, 5 pages, 2014.
10. C. Park, N. Yu, I. Choi, W. Kim, and S. Lee, "lncRNAtor: a comprehensive resource for functional investigation of long non-coding RNAs," Bioinformatics, vol. 30, no. 17, pp. 2480-2485, 2014.
11. Z. X. Chen, D. Sturgill, J. Qu et al., "Comparative validation of the D. melanogaster modENCODE transcriptome annotation," Genome Research, vol. 24, no. 7, pp. 1209-1223, 2014.
12. Z. Chen, J. Li, L. Tian et al., "MiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinoma," Cancer Letters, vol. 350, no. 1-2, pp. 34-42, 2014.
13. M. Hajjari, M. Behmanesh, M. Sadeghizadeh, and M. Zeinoddini, "Up-regulation of HOTAIR long non-coding RNA in human gastric adenocarcinoma tissues," Medical Oncology, vol. 30, no. 3, article 670, 2013.
14. F.Yang, X. Xue, J. Bi et al., "LongnoncodingRNACCAT1,which could be activated by c-Myc, promotes the progression of gastric carcinoma," Journal of Cancer Research and Clinical Oncology, vol. 139, no. 3, pp. 437-445, 2013.
15. W. Sun, Y. Wu, X. Yu et al., "Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance," Tumor Biology, vol. 34, no. 5, pp. 2697-2701, 2013.
16. B. Xiao and J. Guo, "Long noncoding RNA AC096655.1-002 has been officially named as gastric cancer-associated transcript 1, GACAT1," Tumor Biology, vol. 34, no. 5, p. 3271, 2013.
17. D. Mei, H. Song, K. Wang et al., "Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association," Medical Oncology, vol. 30, no. 4, article 709, 2013.
18. J. Sana, P. Faltejskova, M. Svoboda, and O. Slaby, "Novel classes of non-coding RNAs and cancer," Journal of Translational Medicine, vol. 10, no. 1, article 103, 2012.
19. R. Kogo, T. Shimamura, K. Mimori et al., "Long noncoding RNAHOTAIR regulates polycomb-dependent chromatinmodification and is associated with poor prognosis in colorectal cancers," Cancer Research, vol. 71, no. 20, pp. 6320-6326, 2011.
20. K. Panzitt, M. M. O. Tschernatsch, C. Guelly et al., "Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA," Gastroenterology, vol. 132, no. 1, pp. 330-342, 2007.
21. H. Xie, H. Ma, and D. Zhou, "Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma," BioMed Research International, vol. 2013, Article ID 136106, 5 pages, 2013.
22. J.-F. Huang, Y.-J. Guo, C.-X. Zhao et al., "Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) downregulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin," Hepatology, vol. 57,no. 5, pp. 1882-1892, 2013.
23. T. Gutschner, M. Hämmerle, M. Eissmann et al., "The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells," Cancer Research, vol. 73, no. 3, pp. 1180-1189, 2013.
24. E. B. Zhang, D. D. Yin, M. Sun et al., "P53-regulated long noncoding RNA TUG1 affects cell proliferation in human nonsmall cell lung cancer, partly through epigenetically regulating HOXB7 expression," Cell Death and Disease, vol. 5, no. 5,Article ID e1243, 2014.
25. T. Nakagawa, H. Endo, M. Yokoyama et al., "Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human nonsmall cell lung cancer," Biochemical and Biophysical Research Communications, vol. 436, no. 2, pp. 319-324, 2013.
26. J. Yang, J. Lin, T. Liu et al., "Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes," Lung Cancer, vol. 85, no. 2, pp. 110-115, 2014.
27. M. Sun, X.-H. Liu,K.-M.Wang et al., "Downregulation of BRAF activated non-coding RNAis associatedwith poor prognosis for non-small cell lung cancer and promotesmetastasis by affecting epithelial-mesenchymal transition," Molecular Cancer, vol. 13, no. 1, article 68, 2014.
28. A. Renganathan, J. Kresoja-Rakic, N. Echeverry et al., "GAS5 long non-coding RNA in malignant pleural mesothelioma," Molecular Cancer, vol. 13, no. 1, article 119, 2014.
29. K.M.Chisholm, Y.Wan, R. Li,K.D.Montgomery, H. Y. Chang, and R. B.West, "Detection of long non-coding RNA in archival tissue: correlationwith polycomb protein expression in primary and metastatic breast carcinoma," PLoS ONE, vol. 7, no. 10, Article ID e47998, 2012.
30. A. Bhan, I. Hussain, K. I. Ansari, S. Kasiri, A. Bashyal, and S. S. Mandal, "Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol," Journal of Molecular Biology, vol. 425, no. 19, pp. 3707-3722, 2013.
31. L. Lu, G. Zhu, C. Zhang et al., "Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer," Breast Cancer Research and Treatment, vol. 136, no. 3, pp. 875-883, 2012.
32. J. Huang, N. Zhou, K. Watabe et al., "Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1)," Cell Death and Disease, vol. 5, no. 1, p. e1008, 2014.
33. J.-J. Qiu, Y.-Y. Lin, L.-C. Ye et al., "Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer," Gynecologic Oncology, vol. 134, no. 1, pp. 121-128, 2014.
34. Q. Zhang,M. Su,G. Lu, and J.Wang, "The complexity of bladder cancer: long noncoding RNAs are on the stage," Molecular Cancer, vol. 12, no. 1, article 101, 2013.
35. L. Wang, D. Fu, Y. Qiu et al., "Genome-wide screening and identification of long noncoding RNAs and their interaction with protein coding RNAs in bladder urothelial cell carcinoma," Cancer Letters, vol. 349, no. 1, pp. 77-86, 2014.
36. G. Ploussard, X. Durand, E. Xylinas et al., "Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance," European Urology, vol. 59, no. 3, pp. 422-429, 2011.
37. M. J. Roobol, F. H. Schröder, G. L. J. H. Van Leenders et al., "Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in prescreened men: Reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥100)," European Urology, vol. 58, no. 6, pp. 893-899, 2010.
38. A. L. Walsh, A. V. Tuzova, E. M. Bolton, T. H. Lynch, and A. S. Perry, "Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?" Trends in Molecular Medicine, vol. 20, no. 8, pp. 428-436, 2014.
39. G. O. Ifere and G. A. Ananaba, "Prostate Cancer Gene Expression Marker 1 (PCGEM1): a patented prostate-specific noncoding gene and regulator of prostate cancer progression," Recent Patents on DNA and Gene Sequences, vol. 3, no. 3, pp. 151-163, 2009.
40. Y. Shi, Y. Wang, W. Luan et al., "Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675," PLoSONE, vol. 9, no. 1, Article IDe86295, 2014.
41. R. Li, L. Zhang, L. Jia et al., "Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation," PLoS ONE, vol. 9, no. 6, Article ID e100893, 2014.
42. R. A. Gupta, N. Shah, K. C. Wang et al., "Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis," Nature, vol. 464, no. 7291, pp. 1071-1076, 2010.
43. Y. Nie, X. Liu, S. Qu, E. Song, H. Zou, and C. Gong, "Long noncoding RNA HOTAIR is an independent prognosticmarker for nasopharyngeal carcinoma progression and survival," Cancer Science, vol. 104, no. 4, pp. 458-464, 2013.
44. W. Gao, J. Y.-W. Chan, and T.-S.Wong, "Differential expression of long noncoding RNA in primary and recurrent nasopharyngeal carcinoma," BioMed Research International, vol. 2014, Article ID 404567, 9 pages, 2014.
45. A. C. Marques, J. Hughes, B. Graham, M. S. Kowalczyk, D. R. Higgs, and C. P. Ponting, "Chromatin signatures at transcriptional start sites separate two equally populated yet distinct classes of intergenic long noncoding RNAs," Genome Biology, vol. 14, no. 11, article R131, 2013.
46. R. Louro, A. S. Smirnova, and S. Verjovski-Almeida, "Long intronic noncoding RNA transcription: expression noise or expression choice?" Genomics, vol. 93, no. 4, pp. 291-298, 2009.
47. T.Kunej, J.Obsteter, Z. Pogacar, S.Horvat, andG. A. Calin, "The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring," Critical Reviews in Clinical Laboratory Sciences, vol. 51, no. 6, pp. 344-357, 2014.
48. A. M. Khalil, M. Guttman, M. Huarte et al., "Many human large intergenic noncoding RNAs associate with chromatinmodifying complexes and affect gene expression," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 28, pp. 11667-11672, 2009.
49. W. Xie and B. Ren, "Enhancing pluripotency and lineage specification," Science, vol. 341, no. 6143, pp. 245-247, 2013.
50. S. Nakagawa, J. Y. Ip, G. Shioi et al., "Malat1 is not an essential component of nuclear speckles in mice," RNA, vol. 18, no. 8, pp. 1487-1499, 2012.
51. I. Ilik, J. Quinn, P. Georgiev et al., "Tandem stem-loops in roX RNAs act together to mediate X Chromosome dosage compensation in Drosophila," Molecular Cell, vol. 51, no. 2, pp. 156-173, 2013.
52. Y. A. Sytnikova, R. Rahman, G. Chirn, J. P. Clark, and N. C. Lau, "Transposable element dynamics and PIWI regulation impacts lncRNAand gene expression diversity in Drosophila ovarian cell cultures," Genome Research, vol. 24, no. 12, pp. 1977-1990, 2014.
53. J. W. Nam and D. P. Bartel, "Long noncoding RNAs in C. elegans," Genome Research, vol. 22, no. 12, pp. 2529-2540, 2012.
54. Y. Zhang, J. Xia, Q. Li et al., "NRF2/long noncoding RNA ROR signaling regulates mammary stem cell expansion and protects against estrogen genotoxicity," The Journal of Biological Chemistry, vol. 289, no. 45, pp. 31310-31318, 2014.
55. S. He, H. Zhang, H. Liu, and H. Zhu, "LongTarget: a tool to predict lncRNA DNA-binding motifs and binding sites via Hoogsteen base-pairing analysis," Bioinformatics, vol. 31, no. 2, pp. 178-186, 2015.
56. J. C. Schwartz, S. T. Younger, N.-B. Nguyen et al., "Antisense transcripts are targets for activating small RNAs," Nature Structural and Molecular Biology, vol. 15, no. 8, pp. 842-848, 2008.
57. R. J. Taft, C. D. Kaplan, C. Simons, and J. S.Mattick, "Evolution, biogenesis and function of promoter-associated RNAs," Cell Cycle, vol. 8, no. 15, pp. 2332-2338, 2009.
58. J. Han, D. Kim, and K. V. Morris, "Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 30, pp. 12422-12427, 2007.
59. S. Memczak, M. Jens, A. Elefsinioti et al., "Circular RNAs are a large class of animal RNAs with regulatory potency," Nature, vol. 495, no. 7441, pp. 333-338, 2013.
60. K. C.Wang and H. Y. Chang, "Molecular mechanisms of long noncoding RNAs," Molecular Cell, vol. 43, no. 6, pp. 904-914, 2011.
61. E. Leygue, H. Dotzlaw, P. H. Watson, and L. C. Murphy, "Expression of the steroid receptor RNA activator in human breast tumors," Cancer Research, vol. 59, no. 17, pp. 4190-4193, 1999.
62. S. Chooniedass-Kothari, E. Emberley, M. K. Hamedani et al., "The steroid receptor RNA activator is the first functional RNA encoding a protein," FEBS Letters, vol. 566, no. 1-3, pp. 43-47, 2004.
63. D. Ulveling, C. Francastel, and F. Hubé, "When one is better than two: RNA with dual functions," Biochimie, vol. 93, no. 4, pp. 633-644, 2011.
64. J. L. Rinn, M.Kertesz, J. K.Wang et al., "Functional demarcation of active and silent chromatin domains in human HOX Loci by noncoding RNAs," Cell, vol. 129, no. 7, pp. 1311-1323, 2007.
65. M.-C. Tsai, O. Manor, Y. Wan et al., "Long noncoding RNA as modular scaffold of histone modification complexes," Science, vol. 329, no. 5992, pp. 689-693, 2010.
66. E. Pasmant, I. Laurendeau, D. Héron, M. Vidaud, D. Vidaud, and I. Bièche, "Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF," Cancer Research, vol. 67, no. 8, pp. 3963-3969, 2007.
67. E. Pasmant, A. Sabbagh, J. Masliah-Planchon et al., "Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1," Journal of the National Cancer Institute, vol. 103, no. 22, pp. 1713-1722, 2011.
68. E. Pasmant, A. Sabbagh, M. Vidaud, and I. Bièche, "ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS," FASEB Journal, vol. 25, no. 2, pp. 444-448, 2011.
69. L. Shen, L. Chen, Y. Wang, X. Jiang, H. Xia, and Z. Zhuang, "Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer," Journal of Neuro-Oncology, vol. 121, no. 1, pp. 101-108, 2015.
70. J. Wang, X. Liu, H. Wu et al., "CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer," Nucleic Acids Research, vol. 38, no. 16, pp. 5366-5383, 2010.
71. J. H. He, J. Z. Zhang, Z. P. Han, L. Wang, Y. Lv, and Y. G. Li, "Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells," Journal of Experimental & Clinical Cancer Research, vol. 33, no. 1, article 72, 2014.
72. K.-H. Lu,W. Li, X.-H. Liu et al., "Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression," BMC Cancer, vol. 13, article 461, 2013.
73. M. R. Pickard and G. T. Williams, "Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy," Breast Cancer Research and Treatment, vol. 145, no. 2, pp. 359-370, 2014.
74. M. R. Pickard, M. Mourtada-Maarabouni, and G. T. Williams, "Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines," Biochimica et Biophysica Acta, vol. 1832, no. 10, pp. 1613-1623, 2013.
75. R. Kurokawa, "Promoter-associated long noncoding RNAs repress transcription through a RNA binding protein TLS," Advances in Experimental Medicine and Biology, vol. 722, pp. 196-208, 2011.
76. X. Song, X. Wang, S. Arai, and R. Kurokawa, "Promoterassociated noncoding RNA from the CCND1 promoter," Methods in Molecular Biology, vol. 809, pp. 609-622, 2012.
77. G.Wu, J. Cai, Y. Han et al., "LincRNA-p21 regulates neointima formation, vascular smoothmuscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity," Circulation, vol. 130, no. 17, pp. 1452-1465, 2014.
78. V. Pfeiffer and J. Lingner, "TERRA promotes telomere shortening through exonuclease 1-mediated resection of chromosome ends," PLoS Genetics, vol. 8, no. 6,Article ID e1002747, 2012.
79. M. Nordin, D. Bergman, M. Halje, W. Engström, and A. Ward, "Epigenetic regulation of the Igf2/H19 gene cluster," Cell Proliferation, vol. 47, no. 3, pp. 189-199, 2014.
80. S.Marquardt, R. Escalante-Chong, N. Pho et al., "A chromatinbased mechanism for limiting divergent noncoding transcription," Cell, vol. 157, no. 7, pp. 1712-1723, 2014.
81. R. Backofen and T. Vogel, "Biological and bioinformatical approaches to study crosstalk of long-non-coding RNAs and chromatin-modifying proteins," Cell and Tissue Research, vol. 356, no. 3, pp. 507-526, 2014.
82. M.-C. Lai, Z. Yang, L. Zhou et al., "Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation," Medical Oncology, vol. 29, no. 3, pp. 1810-1816, 2012.
83. Z. Yang, L. Zhou, L.-M.Wu et al., "Overexpression of long noncoding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation," Annals of Surgical Oncology, vol. 18, no. 5, pp. 1243-1250, 2011.
84. L. Quagliata, M. S.Matter, S. Piscuoglio et al., "Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients," Hepatology, vol. 59, no. 3, pp. 911-923, 2014.
85. S.-X. Yuan, F. Yang, Y. Yang et al., "Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy," Hepatology, vol. 56, no. 6, pp. 2231-2241, 2012.
86. M. J. G. Bussemakers, A. Van Bokhoven, G. W. Verhaegh et al., "DD3: a new prostate-specific gene, highly overexpressed in prostate cancer," Cancer Research, vol. 59, no. 23, pp. 5975-5979, 1999.
87. M. Hajjari, A. Khoshnevisan, and Y. K. Shin, "Long noncoding RNAs in hematologic malignancies: road to translational research," Frontiers in Genetics, vol. 4, article 250, 2013.
88. E. F. Heuston, K. T. Lemon, and R. J. Arceci, "The beginning of the road for non-coding RNAs in normal hematopoiesis and hematologic malignancies," Frontiers in Genetics, vol. 2, article 94, 2011.
89. C. H. Li and Y. Chen, "Targeting long non-coding RNAs in cancers: progress and prospects," International Journal of Biochemistry and Cell Biology, vol. 45, no. 8, pp. 1895-1910, 2013.
90. L. Ma, M.-S. Chua, O. Andrisani, and S. So, "Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives," World Journal of Gastroenterology, vol. 20, no. 2, pp. 333-345, 2014.
91. T. Gutschner, M. Hämmerle, and S. Diederichs, "MALAT1 - a paradigm for long noncoding RNA function in cancer," Journal of Molecular Medicine, vol. 91, no. 7, pp. 791-801, 2013.
92. F.Yang, J. Bi,X.Xue et al., "Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells," FEBS Journal, vol. 279, no. 17, pp. 3159-3165, 2012.
93. V. Tripathi, Z. Shen, A. Chakraborty et al., "Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB," PLoS Genetics, vol. 9, no. 3,Article ID e1003368, 2013.
94. D. E. Ruffner, G. D. Stormo, and O. C. Uhlenbeck, "Sequence requirements of the hammerhead RNA self-cleavage reaction," Biochemistry, vol. 29, no. 47, pp. 10695-10702, 1990.
95. J. Müller, O. El-Maarri, J. Oldenburg, B. Pötzsch, and G. Mayer, "Monitoring the progression of the in vitro selection of nucleic acid aptamers by denaturing high-performance liquid chromatography," Analytical and Bioanalytical Chemistry, vol. 390, no. 4, pp. 1033-1037, 2008.
96. G. Kolb, S. Reigadas, D. Castanotto et al., "Endogenous expression of an anti-TAR aptamer reduces HIV-1 replication," RNA Biology, vol. 3, no. 4, pp. 150-156, 2006.
97. M. Watrin, F. von Pelchrzim, E. Dausse, R. Schroeder, and J.-J. Toulmé, "In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1," Biochemistry, vol. 48, no. 26, pp. 6278-6284, 2009.
98. C. E. Lünse, G. Michlewski, C. S. Hopp et al., "An aptamer targeting the apical-loop domain modulates pri-miRNA processing," Angewandte Chemie - International Edition, vol. 49, no. 27, pp. 4674-4677, 2010.
99. Y. Wu, Y. Xiao, X. Ding et al., "A mir-200b/200c/429-binding site polymorphism in the 3 untranslated region of the AP-2α gene is associated with cisplatin resistance," PLoS ONE, vol. 6, no. 12, Article ID e29043, 2011.
100. J. Wu, G. Wu, L. Lv et al., "MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1," Carcinogenesis, vol. 33, no. 3, pp. 519-528, 2012.